Saroja Pharma Industries India (NSE:SAROJA) LT-Debt-to-Total-Asset : 0.10 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Saroja Pharma Industries India LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Saroja Pharma Industries India's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.10.

Saroja Pharma Industries India's long-term debt to total assets ratio declined from Mar. 2022 (0.11) to Mar. 2024 (0.10). It may suggest that Saroja Pharma Industries India is progressively becoming less dependent on debt to grow their business.

Saroja Pharma Industries India LT-Debt-to-Total-Asset Historical Data

The historical data trend for Saroja Pharma Industries India's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saroja Pharma Industries India LT-Debt-to-Total-Asset Chart

Saroja Pharma Industries India Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

0.17

0.11

0.13

0.10

Saroja Pharma Industries India Semi-Annual Data
	Mar21	Mar22	Mar23	Mar24
LT-Debt-to-Total-Asset	0.17	0.11	0.13	0.10

Saroja Pharma Industries India LT-Debt-to-Total-Asset Calculation

Saroja Pharma Industries India's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	26.206	/	265.624
	=	0.10

Saroja Pharma Industries India's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	26.206	/	265.624
	=	0.10

Saroja Pharma Industries India (NSE:SAROJA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Saroja Pharma Industries India LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Saroja Pharma Industries India's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Saroja Pharma Industries India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Saroja Pharma Industries India Ltd (NSE:SAROJA) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

Jata Shankar Dosa Marg, Shop No. 209, 2ND Floor, Ecstacy, City of Joy, Mulund west, Mumbai, MH, IND, 400080

Website

https://www.sarojapharma.com

Saroja Pharma Industries India Ltd is a company engaged in pharmaceutical and healthcare sector. The Company trades in Pharma Active Pharmaceutical Ingredients, Pharma Intermediates, Chemicals, Solvents used for pharmaceutical products human and veterinary medicines. The Company has only one reportable Business Segment which is Pharma Chemicals like Thionyl Chloride and Pharmaceuticals intermeddles etc.

Saroja Pharma Industries India Headlines

No Headlines